Optimind Pharma 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

David Goodman

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	less than a year
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	데이터 없음

최근 관리 업데이트

Recent updates

CEO

David Goodman

less than a year

테뉴어

Mr. David Goodman serves as an Independent Director of Predictmedix AI Inc. since December 14, 2023. He was an Independent Director of Optimind Pharma Corp. since October 7, 2022 until January 2024 & serve...

Optimind Pharma 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

Less than half of directors are independent

Less than half of directors are independent

Optimind Pharma Corp. Announces Executive Changes

Optimind Pharma Corp., Annual General Meeting, Jul 20, 2023

Recent updates

Second quarter 2025 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 2Q 2024)

First quarter 2025 earnings released: CA$0.001 loss per share (vs CA$0.004 loss in 1Q 2024)

Optimind Pharma Corp. announced that it expects to receive CAD 0.5 million in funding

Optimind Pharma Corp. announced that it expects to receive CAD 0.5 million in funding

Full year 2024 earnings released: CA$0.014 loss per share (vs CA$0.038 loss in FY 2023)

Less than half of directors are independent

Less than half of directors are independent

Third quarter 2024 earnings released: CA$0.001 loss per share (vs CA$0.01 loss in 3Q 2023)

Optimind Pharma Corp. Announces Executive Changes

Second quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.01 loss in 2Q 2023)

First quarter 2024 earnings released

Optimind Pharma Corp., Annual General Meeting, Jul 20, 2023

Optimind Pharma Corp. (CNSX:OMND) acquired MindSetting Inc. from Beatrice Society Inc. for CAD 1.6 million.

CEO

테뉴어